Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FibroCell-001 Injection for Lumbar Disc Degeneration (Phase I/II)
ChiCTR2500112038Phase 2Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Nov 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised trial of FibroCell-001 in lumbosacral disc disease (7 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoints: Incidence of adverse events and serious adverse events (Phase I), VAS pain scale score (Phase II) and 2 more. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
FibroCell-001
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on ChiCTR2500112038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112038.